Skip to main content

Table 7 Analytical merits for determination of XIP and VAL in pure samples using the proposed HPLC method

From: Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasma

 

XIP

VAL

Conc. taken (µg/mL)

Conc. found (µg/mL)

Recovery %

Accuracy (RE %)

Conc. taken (µg/mL)

Conc. found (µg/mL)

Recovery%

Accuracy (RE %)

 

5

5.07

101.4

1.4

5

5.06

101.31

1.31

 

12.50

12.38

99.06

−0.93

12.50

12.19

97.58

−2.41

 

25

24.71

98.87

−1.12

25

24.95

99.82

−0.17

 

50

50.49

100.98

0.98

50

50.47

100.94

0.94

 

100

99.83

99.83

−0.16

100

99.8

99.8

−0.19

Mean

  

100.03

0.03

  

99.89

−0.1

SD

  

1.12

   

1.45

 

CV (%)

  

1.13

   

1.46

 

SE

  

0.5

   

0.65

 

Variance

  

1.27

   

2.11

 

Slope

  

45.93

   

32.52

 

LOD (µg/mL)m

  

0.075

   

0.134

 

LOQ (µg/mL)m

  

0.248

   

0.448

Â